Company: BSTZ
Filing Date: 2025-01-03
Form Type: SC TO-C
Source: 0001193125-25-000806
Chunk: 1

Company: BlackRock Science & Technology Term Trust
Filing Date: 2025-01-03
Form: SC TO-C
Chunk 1
---
 Dividend Trust                              |     | BDJ    |     | -7.19%                 |
| BlackRock Science and                       
 Technology Trust                            |     | BST    |     | -6.02%                 |
| BlackRock Health Sciences                   
 Trust                                       |     | BME    |     | -8.17%                 |
| BlackRock                                   
 Resources & Commodities Strategy Trust      |     | BCX    |     | -10.00%                |
| BlackRock MuniVest Fund,                    
 Inc.                                        |     | MVF    |     | -8.29%                 |
| BlackRock Utilities,                        
 Infrastructure, & Power Opportunities Trust |     | BUI    |     | -1.32%                 |

1

The Funds’ Boards of Directors/Trustees (the “Boards”) determined that if a Trigger Event occurred during the Quarterly Measurement Period with respect to a Fund, the Fund would offer to repurchase a portion of its outstanding common shares by conducting a tender offer for 2.5% of its outstanding common shares at a price equal to 98% of the Fund’s NAV per share as determined as of the close of the regular trading session of the New York Stock Exchange (“NYSE”) on the next day the NAV is calculated after the expiration date of the tender offer or, if the offer is extended, on the next day the NAV is calculated after the day to which the offer is extended. As a result of the occurrence of a Trigger Event during the Quarterly Measurement Period with respect to each of the following Funds, the Board of each such Fund has authorized the Fund’s tender offer with the anticipated commencement and expiration dates outlined below.

If more than 2.5% of a Fund’s outstanding common shares are tendered, the Fund will purchase its shares from tendering shareholders on a pro rata basis at a price equal to 98% of the Fund’s NAV per share as determined as of the close of the regular trading session of the NYSE on the next day the NAV is calculated after the expiration date of the tender offer (or, if the offer is extended, on the next day the NAV is calculated after the day to which the offer is extended). Accordingly, there is no assurance that a Fund will purchase all of a shareholder’s common shares tendered in the tender offer. Payments for shares tendered and accepted are expected to be made within approximately five business days after the expiration date. The terms and conditions of each Fund’s tender offer will be set forth in